-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
ATAI Life Sciences N.V. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q2 2024.
- ATAI Life Sciences N.V. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$31.3M, a 15467% decline year-over-year.
- ATAI Life Sciences N.V. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $53M, a 1296% increase year-over-year.
- ATAI Life Sciences N.V. annual Nonoperating Income (Expense) for 2023 was $86.2M, a 797% increase from 2022.
- ATAI Life Sciences N.V. annual Nonoperating Income (Expense) for 2022 was $9.61M.
- ATAI Life Sciences N.V. annual Nonoperating Income (Expense) for 2021 was -$796K, a 134% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)